Lincoln National Corp Insulet Corp Transaction History

Lincoln National Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$272.48 - $330.23 $4,087 - $4,953	15 Added 2.01%	761 $219,000
Q1 2023 May 01, 2023	BUY	$276.36 - $326.03 $11,054 - $13,041	40 Added 5.67%	746 $237,000
Q4 2022 Feb 07, 2023	BUY	$212.22 - $313.46 $149,827 - $221,302	706 New	706 $207,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.